W. Gerald Newmin

Anthony Altig

Stephen M. Chang

Thomas A. Page

Edward Sigmnond

W. Gerald Newmin, Chairman of the Board and Acting Chief Financial Officer
(See Executive Profile)

 


 

Anthony Altig, Director
Mr. Anthony Altig was appointed to MultiCell’s Board of Directors in September 2005. Mr. Altig has been senior vice president and CFO of Diversa Corporation (DVSA-NASDAQ), a public biotechnology company, since December 2004. From October 2002 to November 2004, Mr. Altig served as vice president and CFO of Maxim Pharmaceuticals, a biopharmaceutical company. From 2000 to 2001, Mr.

Altig served as executive vice president and CFO for NBC Internet, an Internet consumer media and ecommerce portal company. From 1998 to 2000, Mr. Altig served as executive partner and chief accounting officer of USWeb Corporation (acquired by Whitman-Hart), an Internet professional services firm. Mr. Altig was also a biotechnology and technology client service executive with PricewaterhouseCoopers LLC and KPMG LLC from 1982 to 1998. He is a CPA and a graduate of the University of Hawaii.

 


 

 

Stephen M. Chang, Ph.D., Director
Dr. Stephen Chang has served as a director of the Company since June 2004, became president of the Company in February 2005, and was appointed chief executive officer (CEO) in May 2006. Dr. Chang is also president of MCT Rhode Island Corp. and Xenogenics Corporation, and president, chief financial officer (CFO), treasurer, and director of MCTI, a partially-owned subsidiary of the Company. Dr. Chang is president of CURES, a coalition of patient advocates, biotechnology companies, pharmaceutical companies, and venture capitalists dedicated to ensuring the safety, research, and development of innovative life saving medications. Dr. Chang is also on the Board of BIOCOM, San Diego’s premier life sciences organization. Dr. Chang was chief science officer (CSO) and vice president of Canji Inc./Schering Plough Research Institute in San Diego from 1998 to 2004. He earned his doctoral degree in biological chemistry, molecular biology, and biochemistry from the University of California, Irvine.

 


 

Thomas A. Page, Director
Mr. Thomas Page has served as a director of MultiCell since September 2003. He is director emeritus and former chairman of the Board and CEO of Enova Corporation and San Diego Gas and Electric company (now part of Sempra Energy [SRE-NYSE]). Mr. Page has been active in numerous industrial, community, and governmental associations and has funded medical research. He is a director of the San Diego Regional Economic Development Corporation, Community National Bank, Sys Technologies (SYSAMEX), and is an advisory director of Sorrento Ventures. Mr. Page earned a bachelor of science degree in civil engineering, a master’s in industrial administration, and was awarded a doctorate in management, all from Purdue University. He has been licensed as an engineer and as a CPA. Mr. Page also serves on the University of California Presidents Council on the National Laboratories.

 


 

Edward Sigmond, Director
Mr. Edward Sigmond has served as a director of the Company since May 2000. He has been in sales, marketing, and operations management for the past 20 years. Mr. Sigmond served as president of Kestrel Development, a Texas-based real estate development company from 1993 to 1998, when it was dissolved. He studied marketing and chemistry at Duquesne University.